The decrease of NAD(P)H:quinone oxidoreductase 1 activity and increase of ROS production by NADPH oxidases are early biomarkers in doxorubicin cardiotoxicity
Data(s) |
05/01/2017
05/01/2017
2014
|
---|---|
Resumo |
info:eu-repo/semantics/publishedVersion |
Identificador |
1366-5804 http://hdl.handle.net/10400.8/2352 10.3109/1354750X.2014.885084 |
Idioma(s) |
eng |
Publicador |
Taylor & Francis |
Relação |
http://www.tandfonline.com/doi/abs/10.3109/1354750X.2014.885084 |
Direitos |
openAccess |
Palavras-Chave | #Cellular bioenergetics #NQO1 #Cardiomyopathy #Oxidative stress #Anthracycline #Lipid oxidation #Research Subject Categories::NATURAL SCIENCES::Biology::Cell and molecular biology::Toxicology #Research Subject Categories::MEDICINE::Physiology and pharmacology #Research Subject Categories::MEDICINE::Morphology, cell biology, pathology #Research Subject Categories::MEDICINE::Chemistry::Biochemistry |
Tipo |
article |